Former Board Member at Momenta Pharmaceuticals, Inc.
Dr. Goldenheim joined the NeuroPhage Board of Directors in March 2010. Dr. Goldenheim is trained as a pulmonary physician and is currently working as a director and consultant in the field of biotechnology, serving on the boards of directors of several companies including Alinea, Promedior, and Hydra Biosciences. He has a long history in pharmaceutical research, development, and management, most recently as President of TransForm Pharmaceuticals (acquired by Johnson & Johnson) and Vice-Chairman of the Board of Directors of Hypnion (acquired by Eli Lilly). Paul also serves on the board of directors of The Big Apple Circus. Dr. Goldenheim has a ...
Source: NEUROPHAGE PHARMACEUTICALS INC on 04/28/2006
By accessing BoardEdge, you can view bios, network, connections and references of industry leading executives like Paul D. Goldenheim. More specifically, you'll be able to:
Access over 200,000 executive and board member profiles.
Example: Paul D. Goldenheim
Interested in updating your biography and work history?
We're working on making it happen.
We'll email you when this feature is available.
Please enter valid email address.
Thank you for your interest.